In The News

CNA Honors Long Time Member & Veteran Marilyn Doenges, APRN

November 13, 2018

Happy 96th Birthday to Marilyn Doenges, APRN                                                                                    

Marilynn E. Doenges, APRN, a retired Registered Nurse, has been recognized as an Elite American Nurses for dedication, achievements and leadership in nursing education. She served as a first lieutenant in the United States Army Nurse Corps during World War II and dedicated 68 years of service to the health care field. She left the service in 1946. She received her Bachelor degree in Boulder, married and raised 5 children. She has co-authored nursing care planning texts and pocket guides that are sold worldwide. She has authored and co-authored many nursing books, including “The Nursing Diagnosis Manual: Planning, Individualizing and Documenting Client Care.” Ms. Doenges believes that she was successful throughout her illustrious career because she was passionate about her work and her profession.

 

Nurse for Political Action in Colorado (N-PAC) Candidate Endorsement Results

November 12, 2018

2018 NPAC Endorsements and Report of Results

JARED POLIS – GOVERNOR 

DIANNE PRIMAVERA - LT GOVERNOR

ANNETTE CANNON – JEFFCO COUNTY CORONER (CNA Member)

HOUSE

JEFF BRIDGES - HD 3

JOANN GINAL – HD 5

LOIS LANDGRAF – HD 21

KERRY TIPPER – HD 28                               *

TRACY KRAFT-THARP – HD 29 

DAFNA MICHAELSON JENET –HD 30

YADIRA CARAVEO - HD 31

MATTHEW GRAY – HD 33

MULLICA, KYLE- HD 34 (CNA Member)

SHANNON BIRD, – HD 35

JANET P BUCKNER – HD 40

DANEYA ESGAR – HD 46

BRIANNA BUENTELLO – HD 47 – Recount Pending

 MCKEAN, HUGH – HD 51

BARBARA HALL MCLACHLAN – HD 59 

SENATE

JERRY SONNENBERG – SD 1

LEROY GARCIA – SD 3 (President of the Senate)

SANFORD "PETE" E. LEE – SD 11

TAMMY STORY - SD 16

JESSIE DANIELSON – SD 20

BRITTANY PETTERSEN – SD 22

FAITH WINTER - SD 24

 

 

 

 

DORA Rulemaking Requirements for Carriers Regarding In-Network & Out-of-Network Coverage December 3, 2018

The Department of Regulatory Agencies - Insurance will be holding a rulemaking hearing on Monday, December 3rd, 2018, 2:00 pm on rules regarding 4-2-61. The hearing will be held at: 1560 Broadway, Suite 110 D, Denver CO 80202.

The purpose of this rulemaking is: 

The purpose of this regulation is to establish requirements for carriers to provide in-network cost-sharing for out-of-network emergency room claims and prohibit carriers from limiting coverage for emergency services to only in-network facilities, pursuant to § 10-16-704(5.5), C.R.S. Further, this regulation seeks to address the issue of provider contracting practices and how non-participation in carrier networks may lead to increased premiums and increase the cost of care.

If you believe there will be a significant negative impact on small business, job creation or economic competitiveness, you may request that the Department of Regulatory Agencies require the rulemaking agency to prepare a cost-benefit analysis of a proposed rule or amendment. This request must be made to the Department of Regulatory Agencies by Thursday, November 15th, 2018.

You may also submit comments directly to the rulemaking agency for the agency's consideration during the upcoming rulemaking hearing.

We hope this information is helpful to you. Thank you for taking the time to participate in the rulemaking process.

Brian Tobias
Director
Colorado Office of Policy, Research and Regulatory Refor

 

Notice of Rulemaking- FDA Approval of Stiripentol December 14, 2018

November 6, 2018

The Department of Health Care Policy and Financing - Medical Services will be holding a rulemaking hearing on Friday, December 14th, 2018, 9:00 am on rules regarding FDA Approval of Stiripentol. The hearing will be held at: 303 East 17th Avenue, 11th Floor, Denver CO 80203.

The purpose of this rulemaking is: 

Stiripentol, a drug used to treat an epileptic condition known as Dravet Syndrome, is now FDA approved. Due to the recent FDA approval of Stiripentol, its reference under 10 C.C.R. 2505-10, Section 8.800.4.C.5.a, as a non-FDA approved drug will be deleted. The Department currently covers Stiripentol and will continue covering Stiripentol. This rule change is simply a technical clean-up to remove its designation as a non-FDA approved drug.

If you believe there will be a significant negative impact on small business, job creation or economic competitiveness, you may request that the Department of Regulatory Agencies require the rulemaking agency to prepare a cost-benefit analysis of a proposed rule or amendment. This request must be made to the Department of Regulatory Agencies by Thursday, November 15th, 2018.

You may also submit comments directly to the rulemaking agency for the agency's consideration during the upcoming rulemaking hearing.

 

Rule making - Designation and Maintaining Psychiatric & Residential Treatment Facilities December 14, 2018

November 6, 2018

The Department of Health Care Policy and Financing - Medical Services will be holding a rulemaking hearing on Friday, December 14th, 2018, 9:00 am on rules regarding Psychiatric Residential Treatment Facili. The hearing will be held at: 303 East 17th Avenue, 11th Floor, Denver CO 80203.

The purpose of this rulemaking is: 

The Psychiatric Residential Treatment Facility (PRTF) and Residential Child Care Facility 
(RCCF) rule section at 10 C.C.R. 2505-10, Section 8.765, requires an update to reflect the 
most current diagnostic manual, agency names, statutory references, State Plan 
Amendments, assessment tools, and federal requirements concerning restraint and 
seclusion. To align the rule with current practice, the update also identifies the Colorado 
Department of Human Services' (CDHS) Office of Behavioral Health (OBH) as the agency 
responsible for designating and licensing RCCFs and the requirement that PRTFs be certified 
by CDHS has been removed. Finally, the update includes a provision conerning RCCFs' ability 
to enroll as a separate provider type to render medically necessary services not included in 
the RCCF benefit. While this has always been the case, it is not specified in the current rule.

If you believe there will be a significant negative impact on small business, job creation or economic competitiveness, you may request that the Department of Regulatory Agencies require the rulemaking agency to prepare a cost-benefit analysis of a proposed rule or amendment. This request must be made to the Department of Regulatory Agencies by Thursday, November 15th, 2018.

You may also submit comments directly to the rulemaking agency for the agency's consideration during the upcoming rulemaking hearing.

 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 1 of 40